Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Rieckmann

Showing results (1-10 of 142) with videos related to

Pageof 15
Sort By:
Journal of Neurology|March 21, 2009
Clinical trials in multiple sclerosis: current and future requirements - potential pitfallsP Rieckmann
Medizinische Klinik (Munich, Germany : 1983)|October 18, 2001
[Early multiple sclerosis therapy in the effects of public health economics]P Rieckmann
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|May 11, 2005
Multiple sclerosis therapy: new strategiesP Rieckmann
Drug Safety|February 15, 2000
Managing the adverse effects of interferon-beta therapy in multiple sclerosisA Bayas, P Rieckmann
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|November 24, 2007
Relapsing-remitting multiple sclerosis: what is the potential for combination therapy?M Mäurer, P Rieckmann
Der Ophthalmologe : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft|April 26, 2001
[Optic neuritis. First manifestation of multiple sclerosis? Current diagnostic and therapeutic strategies]G Kiefer, P Rieckmann
Der Nervenarzt|February 1, 1995
[Pathogenesis and therapy of multiple sclerosis. The role of cytokines]F Weber, P Rieckmann
Der Nervenarzt|August 2, 2007
[Recent advances in the pathogenesis and immunotherapy of multiple sclerosis]R Gold, P Rieckmann
Der Nervenarzt|September 24, 2002
[Immunomodulatory staged therapy of multiple sclerosis. New aspects and practical applications, March 2002]P Rieckmann, K V Toyka,
Trends in Neurosciences|August 8, 2001
Multiple sclerosis: more than inflammation and demyelinationP Rieckmann, K J Smith
Pageof 15

Showing results (1-10 of 142) with videos related to

Sort By:
Pageof 15
Journal of Neurology|March 21, 2009
Clinical trials in multiple sclerosis: current and future requirements - potential pitfallsP Rieckmann
Medizinische Klinik (Munich, Germany : 1983)|October 18, 2001
[Early multiple sclerosis therapy in the effects of public health economics]P Rieckmann
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|May 11, 2005
Multiple sclerosis therapy: new strategiesP Rieckmann
Drug Safety|February 15, 2000
Managing the adverse effects of interferon-beta therapy in multiple sclerosisA Bayas, P Rieckmann
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|November 24, 2007
Relapsing-remitting multiple sclerosis: what is the potential for combination therapy?M Mäurer, P Rieckmann
Der Ophthalmologe : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft|April 26, 2001
[Optic neuritis. First manifestation of multiple sclerosis? Current diagnostic and therapeutic strategies]G Kiefer, P Rieckmann
Der Nervenarzt|February 1, 1995
[Pathogenesis and therapy of multiple sclerosis. The role of cytokines]F Weber, P Rieckmann
Der Nervenarzt|August 2, 2007
[Recent advances in the pathogenesis and immunotherapy of multiple sclerosis]R Gold, P Rieckmann
Der Nervenarzt|September 24, 2002
[Immunomodulatory staged therapy of multiple sclerosis. New aspects and practical applications, March 2002]P Rieckmann, K V Toyka,
Trends in Neurosciences|August 8, 2001
Multiple sclerosis: more than inflammation and demyelinationP Rieckmann, K J Smith
Pageof 15